`
`CENTER FOR DRUG EVALUATION AND
`RESEARCH
`
`
`APPLICATION NUMBER:
`
`201280Orig1s000
`
`OFFICER/EMPLOYEE LIST
`
`
`
`
`
`
`Officer/Employee List
`
`NDA 201280
`
`The following officers or employees of FDA participated in the decision to approve this
`supplement and consented to be identified:
`
`Susan Leibenhaut, M.D.
`Paul Brown, Ph.D.
`Khushboo Sharma, M.S.
`Carol Holquist, RPh
`Mary Dempsey
`Matt Soukup, Ph.D.
`Yelena Maslov, Pharm.D.
`Karl Lin, Ph.D.
`Margarita Tossa, M.S.
`John Bishai, Ph.D.
`Lina Aljuburi, Pharm.D., M.S.
`Don Henry
`Angelica Dorantes, Ph.D.
`Patrick Marroum, Ph.D.
`Ali Al Hakim, Ph.D.
`Todd Sahlroot, Ph.D.
`Curtis Rosebraugh, M.D., M.P.H.
`Amy Egan, M.D., M.P.H.
`Mildred Wright
`Raymond Chiang, M.S.
`David Jacobson-Kram, Ph.D.
`Ilan Irony, M.D.
`Sally Choe, Ph.D.
`Lisa Mathis, M.D.
`Enid Galliers
`Adele Seifried
`Olen Stephens, Ph.D.
`David Carlson, Ph.D.
`Alyson Karesh, M.D.
`Zachary Oleszczuk, Pharm.D.
`Tejashri Purohit-Sheth, M.D.
`Suong Tran, Ph.D.
`Sandra Suarez, Ph.D.
`Sheldon Markofsky, Ph.D.
`Melissa Hulett, RN, BSN, MSBA
`Todd Bourcier, Ph.D.
`Twanda Scales, MSN, RN
`
`
`
`Lokesh Jain, Ph.D.
`Aloka Chakravarty, Ph.D.
`Wei Liu, Ph.D.
`Karl Lin, Ph.D.
`Eric Duffy, Ph.D.
`Xiao Ding, Ph.D.
`Hari Sachs, M.D.
`
`